Vanda Pharmaceuticals Inc (VNDA):企業の財務・戦略的SWOT分析

◆英語タイトル:Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140528FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vanda Pharmaceuticals Inc (VNDA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vanda Pharmaceuticals Inc (Vanda) is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour sleep-wake disorder; and Fanapt, an atypical antipsychotic for the treatment of schizophrenia in adults. Its pipeline portfolio includes Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist for pruritus in atopic dermatitis; VQW-765, an alpha-7 nicotinic acetylcholine receptor for CNS disorders; and VTR-297 for oncology indications. Vanda is headquartered in Washington DC, the US.

Vanda Pharmaceuticals Inc Key Recent Developments

Oct 28,2020: Vanda Pharmaceuticals reports third quarter 2020 financial results
Aug 05,2020: Vanda Pharmaceuticals reports second quarter 2020 financial results
May 20,2020: Vanda Pharmaceuticals wins motion to dismiss False Claims Act Lawsuit
May 20,2020: Vanda Pharmaceuticals CEO’s proposal on clinical trial data sharing, covid-19 and Remdesivir
May 06,2020: Vanda Pharmaceuticals reports first quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vanda Pharmaceuticals Inc – Key Facts
Vanda Pharmaceuticals Inc – Key Employees
Vanda Pharmaceuticals Inc – Key Employee Biographies
Vanda Pharmaceuticals Inc – Major Products and Services
Vanda Pharmaceuticals Inc – History
Vanda Pharmaceuticals Inc – Company Statement
Vanda Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vanda Pharmaceuticals Inc – Business Description
Product Category: Fanapt
Overview
Performance
Product Category: HETLIOZ
Overview
Performance
R&D Overview
Vanda Pharmaceuticals Inc – Corporate Strategy
Vanda Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Vanda Pharmaceuticals Inc – Strengths
Vanda Pharmaceuticals Inc – Weaknesses
Vanda Pharmaceuticals Inc – Opportunities
Vanda Pharmaceuticals Inc – Threats
Vanda Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Vanda Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 28, 2020: Vanda Pharmaceuticals reports third quarter 2020 financial results
Aug 05, 2020: Vanda Pharmaceuticals reports second quarter 2020 financial results
May 20, 2020: Vanda Pharmaceuticals wins motion to dismiss False Claims Act Lawsuit
May 20, 2020: Vanda Pharmaceuticals CEO’s proposal on clinical trial data sharing, covid-19 and Remdesivir
May 06, 2020: Vanda Pharmaceuticals reports first quarter 2020 financial results
Apr 15, 2020: Vanda pharmaceuticals announces initiation of “calypso” to study the role of genetic variation in covid-19 infections in collaboration with University of Washington Medicine
Apr 08, 2020: Vanda Pharmaceuticals and The University of Illinois at Chicago announce partnership to identify novel antivirals against COVID-19
Feb 25, 2020: Vanda Pharmaceuticals reports fourth quarter and full year 2019 financial results
Feb 19, 2020: Vanda Pharmaceuticals appoints Stephen Ray Mitchell to Board of Directors
Jan 31, 2020: Vanda Pharmaceuticals comments on court ruling
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Vanda Pharmaceuticals Inc, Key Facts
Vanda Pharmaceuticals Inc, Key Employees
Vanda Pharmaceuticals Inc, Key Employee Biographies
Vanda Pharmaceuticals Inc, Major Products and Services
Vanda Pharmaceuticals Inc, History
Vanda Pharmaceuticals Inc, Subsidiaries
Vanda Pharmaceuticals Inc, Key Competitors
Vanda Pharmaceuticals Inc, Ratios based on current share price
Vanda Pharmaceuticals Inc, Annual Ratios
Vanda Pharmaceuticals Inc, Annual Ratios (Cont...1)
Vanda Pharmaceuticals Inc, Annual Ratios (Cont...2)
Vanda Pharmaceuticals Inc, Interim Ratios
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Vanda Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Vanda Pharmaceuticals Inc (VNDA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PolyOne Corp (POL):企業の財務・戦略的SWOT分析
    PolyOne Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Diagnostics Ltd (Metabolomic Diagnostics) is an early stage medical diagnostic company that develops technology to provide predictive diagnosis of pre-eclampsia in early pregnancy. The company uses metabolic profiling for investigating the low molecular weight biochemicals existi …
  • Saras S.p.A. (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Extraction Oil & Gas Inc (XOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Extraction Oil & Gas Inc (Extraction Oil & Gas), formerly known as Extraction Oil & Gas LLC, is an independent upstream oil and gas company which focuses on the acquisition, development and production of oil, natural gas and natural gas liquids reserves in the Rocky Mountains. The company pr …
  • W.W. Grainger, Inc.:企業の戦略・SWOT・財務情報
    W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report Summary W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NuVascular Technologies Inc:企業の製品パイプライン分析2018
    Summary NuVascular Technologies Inc (NuVascular Technologies) is a developer of medical devices for the treatment of patients suffering from end-stage renal diseases. The company offers hemodialysis access grafts, arteriovenous suture, central venous catheter cuffs, drug-eluting vessel wrap, drug-el …
  • Enka Power:企業の戦略的SWOT分析
    Enka Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • China Mengniu Dairy Co Ltd:企業の戦略・SWOT・財務情報
    China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. …
  • Ck Hutchison Holdings Ltd
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Method Products, Inc.:企業の戦略的SWOT分析
    Method Products, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Commonwealth Bank of Australia:戦略・SWOT・企業財務分析
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gazprom (GAZP):電力:M&Aディール及び事業提携情報
    Summary Gazprom is an integrated global oil and gas company. It carries out the exploration, production, transportation, storage, processing and marketing of natural gas, gas condensate and crude oil. The company also sells gas as a vehicle fuel and participates in the generation and marketing of he …
  • Albertsons Companies, Inc.:戦略・SWOT・企業財務分析
    Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kallpa Generacion SA:発電所・企業SWOT分析
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Sinopec Oilfield Service Corp (600871):石油・ガス:M&Aディール及び事業提携情報
    Summary Sinopec Oilfield Service Corp (SOSC), formerly Sinopec Yizheng Chemical Fibre Company Ltd, is an integrated oil field service company. It operates as a subsidiary of China Petroleum & Chemical Corporation. The company provides integrated and full industrial-chain services covering the entire …
  • New Gold Inc:企業の戦略・SWOT・財務分析
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • British Gas Ltd-エネルギー分野:企業M&A・提携分析
    Summary British Gas Limited (British Gas), a subsidiary of Centrica plc, is an energy utility company that undertakes the distribution of gas and electricity. It supplies electricity and gas to residential retail; commercial wholesale; and small, medium and large industrial customers. The company al …
  • Shenogen Pharma Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shenogen Pharma Group Ltd (Shenogen) is a drug discovery and development company that develops therapeutics for cancer treatment. The company develops biologic drugs and small molecule targeted at the new estrogen receptor variant. It provides SNG-162 that is a small molecule naturally deriv …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆